Opinion of Patients Under Treatment That Meets the Criteria of New Treatment Strategy According to GINA 2006 (EPAGGELIA)

AstraZeneca

Status: Completed

Conditions: New Strategies; Patient Opinion; GINA 2006

Study type: Observational

Funder types: Industry

Identifiers

NCT00695357

NIS-RGR-DUM-2008/1

Details and patient eligibility

About

Cross-sectional, one visit study. All the data will be collected through questionnaires. Descriptives statistics will be applied to the data. 832 patients will participate to the study and 104 physicians.

Enrollment: 832 estimated patients

Sex: All

Ages: 18+ years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• Patients diagnosed with persistent asthma (GINA 2005) for at least 6 months before entering the study
• Patients who are under treatment according to the new strategies described in GINA 2006 for at least 3 months before entering the study

Exclusion criteria

• Patients who are not willing to sign the Informed Consent Form
• COPD Patients